Navigation Links
MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
Date:4/15/2008

GAITHERSBURG, Md., April 15 /PRNewswire/ -- MedImmune today announced that it has advanced its efforts to develop CAT-354, a potential treatment for patients with asthma, with the start of two new trials with a monoclonal antibody (MAb) targeting interleukin-13 (IL-13). One of the studies is a Phase 2 clinical trial in Europe and Australia designed to assess the potential of the anti-IL-13 MAb in patients with uncontrolled asthma despite optimal treatment. The company has also begun dosing patients in the first U.S.-based clinical trial of the antibody, a Phase 1 study to assess pharmacokinetics in healthy adult patients.

"We are pleased to advance CAT-354 into its first Phase 2 clinical trial to assess the antibody's potential to help patients with asthma gain control of their often debilitating symptoms," said Barbara White, M.D., vice president, clinical development, inflammatory disease. "Initiating our clinical work in the U.S. is also an important step in bolstering the depth of data we are gathering for this potential asthma treatment."

The Phase 2 clinical trial is designed to assess the effects of CAT-354 on airway hyperresponsiveness in patients with uncontrolled asthma. This randomized, double-blind, placebo-controlled study has started in Europe and Australia.

The first Phase 1 clinical trial of CAT-354 in the U.S. is designed to compare the pharmacokinetics of the antibody when administered via subcutaneous injection versus intravenous infusion in healthy patients. This randomized, open-label, study in healthy male patients marks the first clinical trial to assess the subcutaneous administration of CAT-354, as previous studies have used intravenous infusion administration.

CAT-354, a recombinant human monoclonal antibody of the G4 subclass, targets IL-13. Early pre-clinical data have shown the potential of the antibody to treat varying degrees of asthma. The effects of CAT-354 have been investigated in in vitro and in
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
5. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Today, iHealth Lab Inc. announced it ... Ltd. for its first institutional round of funding. The ... global reach, accelerate growth and innovation, and invest in ... investment, Xiaomi Ventures will join iHealth,s board of directors, ... and ecommerce. "We are very pleased to ...
(Date:9/19/2014)... 19, 2014 Kiromic, LLC, a Lubbock ... Kent Hance , the former chancellor of Texas Tech University, ... chancellor in July 2014, after raising $1.2 billion for the ... Kent Hance , the most successful chancellor in the history ... only as an investor, but also as our new vice ...
(Date:9/19/2014)... , Sept. 19, 2014  For Cloud Pharmaceuticals, ... design and development, partnering is an integral part ... to design new drugs and identify early stage, ... to further their development. The company also partners ... support this business model, Cloud Pharmaceuticals will be ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... Nov. 11, 2010 MedClean Technologies (OTC Bulletin Board: ... technology for the treatment and disposal of medical waste ... today announced it has signed an agreement with Gamma ... of a MedClean 4500 fixed-based sterilization system. ...
... 2010 Royal Philips Electronics ... technology, today announced that its entire line of emergency ... Heart Association Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency ... also released its Guidelines for Resuscitation 2010 and Philips ...
Cached Medicine Technology:MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables 2MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables 3MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables 4Philips Announces Its Portfolio of Lifesaving Solutions Supports New American Heart Association 2010 CPR and ECC Guidelines 2Philips Announces Its Portfolio of Lifesaving Solutions Supports New American Heart Association 2010 CPR and ECC Guidelines 3Philips Announces Its Portfolio of Lifesaving Solutions Supports New American Heart Association 2010 CPR and ECC Guidelines 4
(Date:9/21/2014)... 2014 Top10BestSEOHosting.com, a leading review ... and GreenGeeks are the most recommended hosting suppliers ... high quality hosting products. , “Don’t waste ... we recommend two great hosting companies to you,” ... that iPage and GreenGeeks are the most recommended ...
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s dresses and ... announced evening cocktail dresses . As a matter ... are very popular among worldwide customers. Now, all its ... to 65 percent off). , All UWDress.com’s employees ... outfits for the global clients. The company is famous ...
(Date:9/20/2014)... Weight Destroyer , a weight ... Michael Wren that has already helped tens of thousands ... conditions like high blood pressure, high cholesterol, and accelerated ... an investigative review. , “Weight Destroyer is totally ... by showing people what is truly effective when it ...
(Date:9/20/2014)... Atlanta, GA (PRWEB) September 20, 2014 ... September 20, 2014. The first poster looked at the ... per cardiac cycle for calculating diastolic function. In conjunction ... with end-stage renal disease and normal LVEF by echo ... high-dose stress protocol, and standard SPECT. Emory Toolbox ...
(Date:9/20/2014)... 20, 2014 Villa del Palmar at ... not experience any damage in relation to Hurricane Odile ... available. , Hurricane Odile struck Cabo San Lucas the ... and powerful surf conditions. Located on the east side ... Loreto experienced some heavy rain, but no damage whatsoever ...
Breaking Medicine News(10 mins):Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3
... counts soar when evergreens are brought indoors, researchers find , , ... live Christmas tree marks the beginning of the holiday season ... trigger weeks of suffering for some, a new study shows. ... a live Christmas tree rose to five times the normal ...
... LOS ANGELES, Nov. 16 Neutrogena(R), a worldwide ... cosmetics, announced today that actress Diane Lane has ... Ms. Lane is a captivating and inspiring ... beauty and daring spirit. In her new,role, she ...
... Allscripts, the leading,provider of clinical software, ... improve healthcare, on behalf of the National,ePrescribing ... for Medicare and Medicaid Services (CMS) proposal ... used by participants in the Medicare,prescription drug ...
... Directors and Reject ... Ramius, Opposition Slate, ... today mailed the following letter to all shareholders from,Lawrence Saper, ... the Company,s Annual Meeting of Shareholders scheduled for,Thursday, December 20, ...
... 16 Schering-Plough,Corporation (NYSE: SGP ) today ... U.S. Federal Trade Commission (FTC) regarding its,planned acquisition ... as,announced March 12, 2007. Organon BioSciences is ... Intervet, the animal health business. It also,includes Nobilon, ...
... Research &,Instrumentation, Inc. (CRi) announced today that their ... Mitalipov to successfully transfer,nuclear genetic material from somatic ... to generate cloned macaque embryos. In a soon ... Oregon National Primate,Research Center and the Oregon Stem ...
Cached Medicine News:Health News:Live Christmas Trees Can Trigger Mold Allergies 2Health News:Live Christmas Trees Can Trigger Mold Allergies 3Health News:Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador 2Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 2Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 3Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 4Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 5Health News:Datascope Mails Letter to Shareholders 2Health News:Datascope Mails Letter to Shareholders 3Health News:Datascope Mails Letter to Shareholders 4Health News:Datascope Mails Letter to Shareholders 5Health News:Datascope Mails Letter to Shareholders 6Health News:Datascope Mails Letter to Shareholders 7Health News:Datascope Mails Letter to Shareholders 8Health News:Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V. 2Health News:Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates 2
... Knee Brace uses muscle power to place ... MA) directed force against the knee during ... mild to moderate symptomatic lateral or medial ... Bledsoe has engineered the Thruster 2.,Indications,Aligner LA ...
... The Bledsoe Sport & Sport Max patellofemoral ... meniscal and/or collateral injuries. Patients with minor ... damage can benefit from added support to ... brace designs to provide the right kind ...
... The Bledsoe Original Knee Brace gives ... For positive ROM control, this brace features ... extension and flexion from 0-120, and positively ... Designed with two eccentric cam slots, the ...
... Bledsoe Revolution Knee Brace ... fitting under post-op conditions. ... surgeon or authorized technician ... fitting and application that ...
Medicine Products: